Combination of a prostaglandin agonist and a HMG-CoA reductase inhibitor for the stimulation of bone growth

摘要

This invention relates to pharmaceutical combinations of a prostaglandin agonist and a HMG-CoA reductase inhibitor, methods of using such combinations and kits containing such combinations. The pharmaceutical combinations, methods and kits are useful to enhance bone formation in mammals, including humans.